Clinical Decision Support Systems (CDSS) Market

7500+ companies worldwide approach us every year for their revenue growth inititatives
Global top 2000 strategist rely on us for their growth strategies.
80% of fortune 2000 companies rely on our research to identify new revenue sources.
30000 High Growth Opportunities
95% renewal rate
KNOW MORE
  1. HOME
  2. Top Market Reports
  3. Clinical Decision Support Systems (CDSS) Market

Clinical Decision Support Systems (CDSS) Market by Component (Services, Software), Delivery (On-premise, Cloud), Product (Standalone, Integrated), Application (Advanced, Therapeutic, Diagnostic), Interactivity (Active, Passive) - Global Forecasts to 2027

FREE BROCHURE FREE SAMPLE REPORT
Report Code: HIT 2237 Jul, 2022, by marketsandmarkets.com

[231 Pages Report] The global clinical decision support systems market is projected to reach USD 2.2 billion by 2027 from USD 1.5 billion in 2022, at a CAGR of 7.9% during the forecast period. The growth of this market is driven by the various government regulations and initiatives that are implemented to promote the adoption of HICT solutions, increase in the  adoption of CDSS-enabled EHRs, growing collaborations and partnerships between stakeholders and various market players, increase in the medication errors, and the development of mHealth and big data tools. However, high investments  for the implementation of CDSS and inadequate interoperability coupled with rising data security concerns are factors that are expected to restrain the growth of this market during the forecast period.

Clinical Decision Support Systems (CDSS) Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 IMPACT

Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities worldwide have been overwhelmed by the large number of patients visiting them daily. The emergence of this pandemic drives the demand for accurate diagnosis and treatment devices in several countries across the globe. In this regard, clinical decision support systems have proven to be useful, as they allow healthcare providers and organizations to monitor patients using various solutions, such as home blood pressure monitors and pulse oximeters. Moreover, with this disease rapidly spreading across the globe has resulted in a shortage of hospital beds and healthcare workers. This has driven the demand for connected medical devices for vital signs monitoring. The pandemic also increased the need for social distancing among physicians and patients, which has driven the demand for CDSS solutions and the need for the accurate and timely exchange of patient health records. Various players in this market have introduced COVID-19-associated features into their existing EHRs, which are being made available to users free of cost.

Clinical Decision Support Systems MARKET dynamics

Driver: Implementation of government regulations & initiatives to promote the adoption of HCIT solutions

In December 2021, CMS announced the publication of a Federal Register Notice to formalize its decision to exercise enforcement discretion not to take action against certain payer-to-payer data exchange provisions of the May 2020 Interoperability and Patient Access final rule.

In Europe, in 2020, EU Health Ministers signed a declaration to collaborate and set up an eHealth common area that will allow for the free movement of electronic health records across Europe. The declaration also calls for eHealth to be an integral part of the Europe 2020 strategy.

Such initiatives/regulations are expected to further drive the demand and adoption of EHR, which will influence the adoption of CDSS in major markets worldwide.

Restraint: Data security concerns related to cloud-based CDSS

A major concern with cloud-based CDSS is that data that is hosted by the vendor is not as secure as its on-premise counterpart. Information related to patient is considered very sensitive, and a high  privacy needs to be maintained so that this information is accessible to authorized users only. Patient information across various countries is always under the scanner of legal frameworks, such as the data privacy requirements legislated through HIPAA (Health Insurance Portability and Accountability Act). Similarly, the European Union has the EU Data Protection Regulation in place with implications for protecting sensitive health data. Although private clouds offer more access protocols and systems, the healthcare industry is not assured of their effectiveness.

Challenge: Shortage of skilled IT professionals in the healthcare industry

The effective utilization of healthcare IT solutions demands strong IT infrastructure and support within the organization and at the solution provider’s end. In a healthcare organization, there is a continuous need for technical support to maintain the server and network for the operation of clinical workflows and optimum interface speed for healthcare IT systems. If the maintenance of the server or network is inadequate, it leads to the generation of screen loads, which slows down the clinical workflow. The shortage of a trained and skilled workforce in major markets is restraining the adoption and implementation of web-based and on-premise HCIT solutions.

Opportunity: Social media integration and rising technological advancements

Access to media platforms is also an emerging trend in CDSS solutions. For instance, the cloud-based Smart Clinical Decision Support System (Smart CDSS) developed by private researchers has integrated social media data captured for patients with chronic conditions. It combines this data with clinical observations from real encounters in healthcare facilities. The system monitors patients' health conditions, emotions, and interests from their social media interactions. It extracts keywords, concepts, and sentiments from Twitter, e-mail analysis, and other social media platforms and supplies patient-specific data to healthcare providers. This helps health practitioners understand a patient’s behavior & lifestyle, thus improving clinical decision-making. Smart CDSS further uses the input to suggest patient-specific recommendations.

North America accounted for the largest share of the global clinical decision support systems market in 2021.

In 2021, North America accounted for the largest share of the global clinical decision support systems market. The large share of the North American market can be attributed to the significant investments in HCIT solutions, regulatory mandates favoring the implementation of CDSS, the presence of major market players in the region, and the rising number of medication errors in the US and Canada.

Clinical Decision Support Systems (CDSS) Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Key Market Players

Some of the prominent players operating in the CDSS market are Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample
Click on image to enlarge

Scope of the Report

Report Metric

Details

Market size available for years

2020-2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Value (USD Billion)

Segments covered

Component, Product, Type, Model, Application, Delivery Mode, Interactivity Level, Setting, And Region

Geographies covered

North America (US, and Canada), Europe (Germany, France, UK, Italy, Spain, and the RoE), Asia Pacific (Japan, China, India, and RoAPAC), RoW (Latin America and Middle East & Africa)

Companies covered

Cerner Corporation (US), Change Healthcare (US), Epic Systems (US), MEDITECH (US), Philips Healthcare (Netherlands), Wolters Kluwer N.V. (Netherlands), Zynx Health (US), Elsevier B.V. (UK), IBM Watson Health (US), Allscripts Healthcare LLC (US), athenahealth (US), NextGen Healthcare (US), Siemens Healthineers (US), EBSCO Health (US), GE Healthcare (US), eClinicalWorks (US), RAMPMedical (Germany), The Medical Algorithms Company Limited (UK), Hera-MI (France), CureMD Healthcare (US), CareCloud, Inc (US), Visual DX (US), Stanson Health (US), First Databank, Inc (US), and Strata Decision Technology (US).

The study categorizes the clinical decision support systems market into the following segments and subsegments:

By Product

  • Integrated CDSS
  • Standalone CDSS

By Delivery Mode

  • On Premise
  • Cloud based

By Model

  • Knowledge based
  • Non-Knowledge based

By Type

  • Therapeutic
  • Diagnostic

By Component

  • Services
  • Software
  • Hardware

By Application

  • Advanced CDSS
  • Conventional CDSS

By Level of Interactivity

  • Active CDSS
  • Passive CDSS

By Settings

  • In Patient
  • Ambulatory care settings

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • RoW
    • Latin America
    • Middle East and Africa

Recent Developments:

  • In 2022, Allscripts (US) made an agreement to sell Constellation (Canada), the net assets of Allscripts Hospitals and Large Physician Practices business segment. The Hospitals and Large Physician Practices business segment includes the Sunrise™, Paragon®, Allscripts TouchWorks®, Allscripts® Opal, STAR™, HealthQuest™, and dbMotion™ solutions.
  • In 2021, Change Healthcare (US) launched InterQual in partnership with the American Society of Addiction Medicine (ASAM). InterQual seamlessly integrates into existing care-management workflows, significantly reduces the time required for substance use disorder (SUD) patient assessments, increases consistency, and streamlines the prior-authorization process using industry-standard criteria
  • In 2021, (GHA) announced plans to expand Allscripts Sunrise™ electronic health records (EHR) across Victoria, Australia of Gippsland. Phase 3 of GHA’s EHR Community Health project will see the implementation of the Sunrise Emergency Care module (within the Sunrise EHR platform of health) at the emergency department facilities of the Central Gippsland Health Service, Bairnsdale Regional Health Service (servicing east Gippsland), West Gippsland Healthcare Group and Bass Coast Health, which covers the southern part of the region. Sunrise will then be deployed across inpatient services at all four hospitals.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 23)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
           1.2.1 CLINICAL DECISION SUPPORT SYSTEM MARKET: INCLUSIONS & EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 CDSS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
           1.5.1 SCOPE-RELATED LIMITATIONS
           1.5.2 METHODOLOGY-RELATED LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 28)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY RESEARCH
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key industry insights
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION METHODOLOGY
           FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    2.3 MARKET ESTIMATION
           FIGURE 6 RESEARCH METHODOLOGY: MARKET ESTIMATION
           2.3.1 APPROACH: END USER-BASED MARKET ESTIMATION
                    FIGURE 7 MARKET-SIZE ESTIMATION
    2.4 MARKET DATA ESTIMATION AND TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 RISK ASSESSMENT
           TABLE 1 RISK ASSESSMENT: CLINICAL DECISION SUPPORT SYSTEMS MARKET
    2.7 LIMITATIONS

3 EXECUTIVE SUMMARY (Page No. - 39)
    FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET

4 PREMIUM INSIGHTS (Page No. - 46)
    4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
           FIGURE 18 RISING GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS DRIVE THE MARKET GROWTH
    4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
           FIGURE 19 US DOMINATED THE MARKET IN NORTH AMERICA (2021)
    4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT
           FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET FROM 2022 TO 2027
    4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
           FIGURE 21 ASIA PACIFIC TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 49)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Implementation of government regulations & initiatives to promote the adoption of HCIT solutions
                    5.2.1.2 Increasing adoption of CDSS-enabled EHRs
                    5.2.1.3 Growing collaborations & partnerships among stakeholders
           TABLE 2 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 2020 TO 2022
                    5.2.1.4 Growing incidence of medication errors
                    5.2.1.5 Development of big data and mHealth tools
           5.2.2 RESTRAINTS
                    5.2.2.1 Data security concerns related to cloud-based CDSS
                    5.2.2.2 Inadequate interoperability
           5.2.3 OPPORTUNITIES
                    5.2.3.1 The growth potential of emerging markets
                    5.2.3.2 Social media integration and rising technological advancements
           5.2.4 CHALLENGES
                    5.2.4.1 Requirement of high investments for the implementation of CDSS infrastructure
                    5.2.4.2 Shortage of skilled IT professionals in the healthcare industry
    5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
    5.4 VALUE-CHAIN ANALYSIS
           FIGURE 23 CLINICAL DECISION SUPPORT SYSTEMS MARKET: VALUE-CHAIN ANALYSIS (2021)
    5.5 CASE STUDIES
           5.5.1 IMPROVING RESPONSE PHYSICIAN EFFICIENCY AND TIME
                    TABLE 3 CASE 1: NEED TO PROVIDE BETTER FACILITIES
           5.5.2 IMPROVING EFFICIENCY AND CARE WITH AI
                    TABLE 4 CASE 2: IMPROVING EFFICIENCY, ADOPTION, AND CARE EXPERIENCES WITH AI-POWERED CDS
           5.5.3 PROVIDING THE BEST PATIENT CARE
                    TABLE 5 CASE 3: FOCUS ON QUALITY AND SAFETY
    5.6 ECOSYSTEM ANALYSIS
           FIGURE 24 CLINICAL DECISION SUPPORT SYSTEM MARKET: ECO SYSTEM ANALYSIS (2021)
    5.7 TECHNOLOGY ANALYSIS
           TABLE 6 TECHNOLOGICAL DEVELOPMENTS BY LEADING VENDORS
    5.8 REGULATORY ANALYSIS
           5.8.1 HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT OF 1996 (HIPAA)
           5.8.2 HEALTH INFORMATION TECHNOLOGY FOR ECONOMIC AND CLINICAL HEALTH ACT OF 2009 (HITECH)
           5.8.3 CONSUMER PRIVACY PROTECTION ACT OF 2017
           5.8.4 NATIONAL CYBERSECURITY PROTECTION ADVANCEMENT ACT OF 2015
           5.8.5 CYBERSECURITY LAW OF THE PEOPLE’S REPUBLIC OF CHINA
           5.8.6 AFFORDABLE CARE ACT, 2010
    5.9 PORTER'S FIVE FORCES ANALYSIS
           TABLE 7 CDSS MARKET: PORTER’S FIVE FORCES ANALYSIS
    5.10 INDUSTRY TRENDS
           5.10.1 RISING NEED FOR INTEROPERABILITY & INTEGRATION FOR HCIT SOLUTIONS
           5.10.2 GRADUAL SHIFT OF ACCOUNTABILITY FROM PAYERS TO PROVIDERS
           5.10.3 GROWING DEMAND FOR VALUE-BASED HEALTHCARE
    5.11 PRICING ANALYSIS
           TABLE 8 AVERAGE SELLING PRICE OF CDSS SOLUTIONS, BY PRODUCT (2021)
    5.12 CONFERENCES AND WEBINARS
    5.13 BUSINESS MODELS
           FIGURE 25 BENEFITS OF HYBRID BUSINESS MODELS

6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT (Page No. - 66)
    6.1 INTRODUCTION
           TABLE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
    6.2 SERVICES
           6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET FROM 2022–2027
                    TABLE 10 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.3 SOFTWARE
           6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES
                    TABLE 11 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 2020–2027 (USD MILLION)
    6.4 HARDWARE
           6.4.1 HARDWARE MUST BE FREQUENTLY UPGRADED OR REPLACED FOR THE OPTIMAL USE OF ADVANCED SOFTWARE
                    TABLE 12 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 2020–2027 (USD MILLION)

7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT (Page No. - 71)
    7.1 INTRODUCTION
           TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    7.2 INTEGRATED CDSS
           7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS TO IMPROVE THE QUALITY OF CARE AND REDUCE MEDICATION ERRORS
                    TABLE 14 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 STANDALONE CDSS
           7.3.1 LACK OF INTEROPERABILITY WITH CPOE AND EHR TO RESTRAIN THE MARKET DEMAND
                    TABLE 15 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE (Page No. - 75)
    8.1 INTRODUCTION
           TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
    8.2 THERAPEUTIC CDSS
           8.2.1 THERAPEUTIC CDSS IS MOST EFFECTIVE IN INTEGRATED CLINICAL WORKFLOWS AS IT REDUCES MEDICATION ERRORS
                    TABLE 17 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.3 DIAGNOSTIC CDSS
           8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH A SYSTEMATIC DIAGNOSIS PROCESS
                    TABLE 18 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (Page No. - 78)
    9.1 INTRODUCTION
           TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
    9.2 KNOWLEDGE-BASED CDSS
           9.2.1 KNOWLEDGE-BASED CDSS MODELS USE CONDITIONAL LOGIC FOR DECISION-MAKING AND PROBLEM ANALYSIS
                    TABLE 20 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.3 NON-KNOWLEDGE-BASED CDSS
           9.3.1 NON-KNOWLEDGE-BASED CDSS IMPLEMENTS ML AND AI ALGORITHMS TO EXPAND ITS USER-DEFINED KNOWLEDGE BASE
                    TABLE 21 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE (Page No. - 82)
     10.1 INTRODUCTION
           TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
     10.2 ON-PREMISE CDSS
             10.2.1 LICENSED SOFTWARE IS INSTALLED ON ON-PREMISE CDSS DELIVERY MODES
                        TABLE 23 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.3 CLOUD-BASED CDSS
             10.3.1 CLOUD-BASED CDSS IS PROJECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
                        TABLE 24 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (Page No. - 86)
     11.1 INTRODUCTION
           TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
     11.2 CONVENTIONAL CDSS
             11.2.1 CONVENTIONAL CDSS IS USED TO ENHANCE HEALTH-RELATED DECISION-MAKING
                        TABLE 26 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
     11.3 ADVANCED CDSS
             11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD
                        TABLE 27 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL (Page No. - 90)
     12.1 INTRODUCTION
           TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
     12.2 ACTIVE CDSS
             12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET
                        TABLE 29 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
     12.3 PASSIVE CDSS
             12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS
                        TABLE 30 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)

13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING (Page No. - 94)
     13.1 INTRODUCTION
           TABLE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
     13.2 INPATIENT SETTINGS
             13.2.1 THE ADOPTION OF CDSS FOR INPATIENT SETTINGS HELPS IMPROVE PATIENT CARE WORKFLOWS
                        TABLE 32 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 2020–2027 (USD MILLION)
     13.3 AMBULATORY CARE SETTINGS
             13.3.1 THE RISING NEED TO CONTROL HEALTHCARE COSTS DRIVES THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS
                        TABLE 33 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 2020–2027 (USD MILLION)

14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION (Page No. - 98)
     14.1 INTRODUCTION
             FIGURE 26 NORTH AMERICA TO DOMINATE THE CDSS MARKET FROM 2022 TO 2027
             TABLE 34 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
     14.2 NORTH AMERICA
             FIGURE 27 NORTH AMERICA: CDSS MARKET SNAPSHOT
             TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
             TABLE 38 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 39 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 40 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
             TABLE 41 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
             TABLE 42 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 43 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.2.1 US
                        14.2.1.1 The US is the largest market for CDSS solutions
                                     TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 46 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 47 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 48 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 49 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 50 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 51 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.2.2 CANADA
                        14.2.2.1 The rising requirement for cost containment drives the market growth in Canada
                                     TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 54 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 55 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 56 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 57 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 58 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 59 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
     14.3 EUROPE
             TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
             TABLE 63 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 64 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 65 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
             TABLE 66 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
             TABLE 67 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 68 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.1 GERMANY
                        14.3.1.1 Government initiatives to boost the adoption of EMRs drives the market growth in Germany
                                     TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 71 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 72 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 73 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 74 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 75 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 76 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.2 UK
                        14.3.2.1 Favorable government initiatives drive the demand for CDSS solutions in the UK
                                     TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 79 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 80 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 81 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 82 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 83 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 84 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.3 FRANCE
                        14.3.3.1 The rising focus on improving the healthcare system in France drives the market demand for CDSS
                                     TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 87 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 88 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 89 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 90 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 91 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 92 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.4 ITALY
                        14.3.4.1 The growing burden of chronic diseases drives the adoption of EHR solutions in Italy
                                     TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 95 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 96 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 97 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 98 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 99 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 100 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.5 SPAIN
                        14.3.5.1 Growing cases of COVID-19 have driven the demand for evidence-based solutions in Spain
                                     TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 103 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 104 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 105 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 106 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 107 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 108 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.3.6 REST OF EUROPE
                        TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                        TABLE 111 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 112 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 113 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                        TABLE 114 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                        TABLE 115 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 116 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
     14.4 ASIA PACIFIC
             FIGURE 28 ASIA PACIFIC: CDSS MARKET SNAPSHOT
             TABLE 117 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 118 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 119 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
             TABLE 120 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 121 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 122 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
             TABLE 123 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
             TABLE 124 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 125 ASIA PACIFIC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.4.1 JAPAN
                        14.4.1.1 The rising geriatric population in Japan supports the adoption of evidence-based clinical decisions using CDSS
                                     TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 128 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 129 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 130 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 131 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 132 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 133 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.4.2 CHINA
                        14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms
                                     TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 136 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 137 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 138 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 139 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 140 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 141 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.4.3 INDIA
                        14.4.3.1 The high burden of chronic diseases in India supports the market adoption of CDSS-based solutions
                                     TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 144 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 145 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 146 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 147 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 148 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 149 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.4.4 REST OF ASIA PACIFIC (ROAPAC)
                        TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                        TABLE 152 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                        TABLE 153 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 154 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                        TABLE 155 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                        TABLE 156 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 157 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
     14.5 REST OF THE WORLD
             TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 2020–2027 (USD MILLION)
             TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
             TABLE 161 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
             TABLE 162 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 163 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
             TABLE 164 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
             TABLE 165 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 166 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.5.1 LATIN AMERICA
                        14.5.1.1 Developments in healthcare infrastructure support the market growth in Latin America
                                     TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 169 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 170 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 171 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 172 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 173 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 174 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)
             14.5.2 MIDDLE EAST & AFRICA
                        14.5.2.1 Growing medical tourism supports the market adoption of CDSS in the Middle East & Africa
                                     TABLE 175 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                     TABLE 176 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION)
                                     TABLE 177 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                     TABLE 178 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                     TABLE 179 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020–2027 (USD MILLION)
                                     TABLE 180 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY INTERACTIVITY LEVEL, 2020–2027 (USD MILLION)
                                     TABLE 181 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                     TABLE 182 MIDDLE EAST & AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020–2027 (USD MILLION)

15 COMPETITIVE LANDSCAPE (Page No. - 160)
     15.1 OVERVIEW
     15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
             TABLE 183 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
     15.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS
             FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
     15.4 MARKET RANKING OF PLAYERS, 2021
             FIGURE 30 CLINICAL DECISION SUPPORT SYSTEMS MARKET RANKING, BY KEY PLAYER, 2021
     15.5 COMPETITIVE BENCHMARKING
             TABLE 184 CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
             TABLE 185 CLINICAL DECISION SUPPORT SYSTEMS MARKET: APPLICATION & PRODUCT FOOTPRINT OF KEY PLAYERS
             TABLE 186 CLINICAL DECISION SUPPORT SYSTEMS MARKET: REGIONAL FOOTPRINT OF KEY PLAYERS
     15.6 COMPETITIVE LEADERSHIP MAPPING
             15.6.1 STARS
             15.6.2 EMERGING LEADERS
             15.6.3 PERVASIVE PLAYERS
             15.6.4 PARTICIPANTS
                        FIGURE 31 CLINICAL DECISION SUPPORT SYSTEMS MARKET (GLOBAL) COMPANY EVALUATION MATRIX, 2021
     15.7 COMPETITIVE LEADERSHIP MAPPING – START-UPS/SMES
             15.7.1 PROGRESSIVE COMPANIES
             15.7.2 STARTING BLOCKS
             15.7.3 RESPONSIVE COMPANIES
             15.7.4 DYNAMIC COMPANIES
                        FIGURE 32 COMPETITIVE LEADERSHIP MAPPING, START-UP/SME MATRIX MARKET
     15.8 COMPETITIVE SITUATIONS AND TRENDS
             TABLE 187 PRODUCT LAUNCHES/ENHANCEMENTS
             15.8.1 DEALS
                        TABLE 188 DEALS, JANUARY 2019–MAY 2022

16 COMPANY PROFILES (Page No. - 180)
(Business overview, Products & services offered, Recent developments & MnM View)* 
     16.1 KEY PLAYERS
             16.1.1 CERNER CORPORATION
                        TABLE 189 CERNER: BUSINESS OVERVIEW
                        FIGURE 33 CERNER CORPORATION: COMPANY SNAPSHOT (2019)
             16.1.2 IBM WATSON HEALTH
                        TABLE 190 IBM: BUSINESS OVERVIEW
                        FIGURE 34 IBM: COMPANY SNAPSHOT (2021)
             16.1.3 CHANGE HEALTHCARE
                        TABLE 191 CHANGE HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 35 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
             16.1.4 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
                        TABLE 192 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.: BUSINESS OVERVIEW
                        FIGURE 36 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             16.1.5 ATHENAHEALTH
                        TABLE 193 ATHENAHEALTH: BUSINESS OVERVIEW
             16.1.6 EPIC SYSTEMS CORPORATION
                        TABLE 194 EPIC SYSTEMS CORPORATION: BUSINESS OVERVIEW
             16.1.7 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
                        TABLE 195 ELSEVIER B.V.: BUSINESS OVERVIEW
             16.1.8 ZYNX HEALTH
                        TABLE 196 ZYNX HEALTH: BUSINESS OVERVIEW
             16.1.9 WOLTERS KLUWER N.V.
                        TABLE 197 WOLTERS KLUWER N.V.: BUSINESS OVERVIEW
                        FIGURE 37 WOLTERS KLUWER N.V.: COMPANY SNAPSHOT (2021)
             16.1.10 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS)
                        TABLE 198 PHILIPS HEALTHCARE: BUSINESS OVERVIEW
                        FIGURE 38 PHILIPS HEALTHCARE: COMPANY SNAPSHOT (2021)
             16.1.11 MEDITECH
                        TABLE 199 MEDITECH: BUSINESS OVERVIEW
*Details on Business overview, Products & services offered, Recent developments & MnM View might not be captured in case of unlisted companies.  
     16.2 OTHER KEY PLAYERS
             16.2.1 NEXTGEN HEALTHCARE
             16.2.2 SIEMENS HEALTHINEERS
             16.2.3 EBSCO HEALTH (A DIVISION OF EBSCO INDUSTRIES, INC.)
             16.2.4 GE HEALTHCARE
             16.2.5 ECLINICALWORKS
             16.2.6 RAMPMEDICAL
             16.2.7 THE MEDICAL ALGORITHMS COMPANY
             16.2.8 HERA-MI
             16.2.9 CUREMD
             16.2.10 CARECLOUD
             16.2.11 VISUALDX
             16.2.12 STANSON HEALTH
             16.2.13 FIRST DATABANK
             16.2.14 STRATA DECISION TECHNOLOGY

17 APPENDIX (Page No. - 224)
     17.1 DISCUSSION GUIDE
     17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     17.3 AVAILABLE CUSTOMIZATIONS
     17.4 RELATED REPORTS
     17.5 AUTHOR DETAILS

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the Clinical decision support systems market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the Clinical decision support systems market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

The secondary sources referred to for this research study include publications from government sources, such as WHO, ATA, AHA and AAHM. Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines and research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global Clinical decision support systems market, which was validated through primary research.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global Clinical decision support systems market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as Individual Physicians, Physician Groups, Hospitals, Clinics and Other Healthcare Facilities, Payers- Private and Public Insurance Bodies, Other End Users- Employer Groups and Government Bodies) and supply-side (such as C-level and D-level executives, product managers, marketing and sales managers of key manufacturers, distributors, and channel partners, among others) across five major regions—North America, Europe, the Asia Pacific, Latin America, Middle East and the Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

Clinical Decision Support Systems (CDSS) Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the size of the CDSS market and various other dependent submarkets. The research methodology used to estimate the market size includes the following details:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The revenue generated from the sale of CDSS products by leading players has been determined through primary and secondary research.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the overall market size, from the market size estimation process explained above, the clinical decision support systems market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market

Report Objectives

  • To define, describe, and forecast the global CDSS market based on product, component, delivery mode, type, model, application, interactivity level, setting, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall clinical decision support systems market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions—North America, Europe, the Asia Pacific, and the Rest of the World (Latin America & the Middle East & Africa)
  • To strategically analyze the market structure and profile the key players and comprehensively analyze their market shares and core competencies2
  • To track and analyze competitive developments such as acquisitions, product launches & enhancements, expansions, agreements, collaborations, and partnerships in the global CDSS market

Available Customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company information

  • Detailed analysis and profiling of additional market players (up to 20)
Clinical Decision Support Systems (CDSS) Market Size, Share & Growth Report
Report Code
HIT 2237
Published ON
Jul, 2022
REQUEST FREE SAMPLE REPORT
Choose License Type
BUY NOW
Inquire Before Buying
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status